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The purpose of the study was to investigate whether or not orally administered salbutamol would affect mucociliary clearance function in the lungs. Salbutamol, 4 mg, was given orally 3 times a day for 7 days to 10 and 9 patients with various chest diseases in stable stage, respectively ; the former were also currently taking other medications and the latter, none. Lung function tests, chest x-rays and radioaerosol inhalation lung cine-scintigraphy were performed before and after the administration of salbutamol. There was little qualitative or quantitative difference in mucociliary clearance function in either group before and after the administration of oral salbutamol, although it induced some increases in VC and FEV1.0 and a decrease in RV TLC ratio in the former and some increases in FEV1.0, FEV1.0% and MMF in the latter. Oral salbutamol seems little to affect the mucociliary clearance function in the lungs. beta-2 agonist, bronchodilation ; mucociliary clearance mechanisms ; radioaerosol inhalation lung cine-scintigraphy ; salbutamol For patients with obstructive airways disease, it is desirable to ease their shortness of breath by adding a bronchodilator to the current regimens they are taking, whether or not the obstructive airways disease is actually reversible with the addition. Some patients actually report benefit with the added bronchodilator despite lack of objective improvement in tests reflecting bronchodilation. Improvement in airway clearance function, however, could also be a reason for the subjective benefit.
Beta agonists are known to induce bronchodilation (Innes and Nickerson 1970) . They have also been shown to affect ciliary beat (Van As 1974) and mucus secretion Melville 1974, 1975) and to regulate movement of chloride and sodium ions across the trachea (Davis et al. 1979) . Radioaerosol inhalation lung cine-scintigraphy is a simple procedure we have proposed to visually and quantitatively evaluate mucociliary clearance mechanisms (Isawa et al. , 1984a ). An evaluation of a drug effect on the mucociliary clearance function in the lungs by using this methodology has been reported (Isawa et al. 1984c) . A simplified revision of the original method has been made and the examination can now be completed in 60 min. The simplified radioaerosol inhalation lung cine-scintigraphy has revealed no difference in the evaluation of mucociliary clearance function in the lungs compared with those obtained by the original radioaerosol inhalation lung cine-scintigraphy (Isawa et al. 1986 ).
The purpose of this clinical investigation was to study by means of this radioaerosol inhalation lung cine-scintigraphy (Isawa et al. , 1984a whether mucociliary clearance function is really effected or not by adding an oral beta-2 agonist, salbutamol, to two groups of patients who were already being treated with other medications and those who were not yet treated, respectively, because oral salbutamol is usually used in combination with other medications.
MATERIALS AND METHODS

Addition of salbutamol to other medications
Ten patients, 7 male and 3 female, with various chest diseases in stable stage as listed in Table 1 who had already been given other medications, were studied. As also seen in Table 1 , the medications used in the patients were as follows ; nine patients (9/10) were treated with mucolytic agents such as bromhexine or cysteine derivatives, two (2/10), anticancer regimens such as cyclophosphamide, mitomycin C and 5-fluorouracil, two (2/10), antibiotics, cefaclor and cefotiam, respectively, three (3/10), tranquilizers, one (1/10) each, antituberculous regimens consisting of isoniazid, ethambutol and rifampi_n, and steroid, respectively. Salbutamol 4 mg was orally added to these regimens 3 times aa day for 7 days. Radioaerosol inhalation lung cine-scintigraphy using ultrasonically generated technetium-99 m tagged human serum albumin aerosol (Isawa et al. , 1984a was performed under a gamma camera connected to a computer before the administration of oral salbutamol and about 60 min after the last dose of oral salbutamol was given on the the 7th day. Mass median diameter (dm) of aerosol used in this study was 3.73 um with geometric standard deviation (o g) of 1.51. ). Measurement of radioactivity was made continuously for 60 min in 10 sec frame mode and no repeat measurement was made 24 hr later each time . Prior to each radioaerosol inhalation lung cinescintigraphy, lung function tests were done to see if there was any change in lung function and chest x-rays were taken in the morning of the same day to make sure that the patients developed no significant parenchymal lung lesions in the preceding one week.
Salbutamol without other medications
In 9 consecutive patients in stable stage, all male, with various chest diseases as listed in Table 2 , radioaerosol inhalation lung cine-scintigraphy (Isawa et al. , 1984a was performed on admission. Then oral salbutamol 4 mg was given singly three times a day for 7 days without giving other medications and the repeat radioaerosol inhalation lung cine-scintigraphy was done on the 7th day. Prior to each scintigraphy lung function tests and chest x-rays were taken in the morning of the same day.
Calculation of indexes
The lung retention ratio (LRR) was calculated from the actually measured radioactiv-ity as described previously (Isawa et al. 1984a, b) . The alveolar deposition ratio (ALDR) which is equivalent to LRR at 24 hr before and after the administration of salbutamol were estimated by putting the respective LRR60 and FEV1.0 O to the formula ALDR --48 .08+0.47 x FEV1.0 O+0.59 x LRR60 . By using the sequential LRR and the ALDR, the airway deposition ratio (ADR), the airway retention ratio (ARR), and the airway clearance efficiency (ACE) before and after the drug administration were calculated as reported previously (Isawa et al. 1984a . In these parameters, the ACE was equivalent to (100-ARR).
Statistical analysis
Paired t-test and chi-square (x2) test were used to analyze the data. When P value was less than 0.05, the difference was considered statistically significant.
RESULTS
Salbutamol with other medications
Lung function tests. Lung function data before and after the administration of salbutamol are shown in Table 1 . Vital capacity (VC) and forced expiratory volume in one second (FEV1.o) significantly increased (p <0.01, respectively) and residual volume (RV) to total lung capacity (TLC) ratio or RV 'TLC significantly decreased (p <0.05) after the addition of oral salbutamol to the current regimens by paired t-test. Chest x-rays. There were little changes on chest x-rays before and after the addition of salbutamol. Radioaerosol inhalation lung cine-scintigraphy, lung retention ratio (LRR), airway deposition ratio (ADR), airway retention ratio (ARR), airway clearance efficiency (ACE) and alveolar deposition ratio (ALDR). It was not possible to tell visually the difference in the distribution of inhaled radioaerosol and mucus clearance patterns in the lungs based on radioaerosol inhalation lung cine-scintigraphy between before and after the addition of salbutamol. In any of the 5 indexes, there was statistically no difference before and after the addition of salbutamol either by chi-square (x2) test or by paired t-test as shown in Fig. 1 .
Salbutamol given singly without other medications
Lung function tests. The results of lung function tests are shown in Table 2 . FEV1.0 to forced vital capacity or FEV1.o% and maximum mid-expiratory flow rate (MMF) significantly increased (p <0.05, respectively) and FEV1.0 also significantly increased (p <0.01) after administration of salbutamol by paired t-test. Chest x-rays. There were little changes on chest x-rays before and after administration of oral salbutamol. Radioaerosol inhalation lung cine-scintigraphy, lung retention ratio (LRR), airway deposition ratio (ADR), airway retention ratio (ARR), airway clearance efficiency (ACE) and alveolar deposition ratio (ALDR). Little visual differences in the distribution of inhaled radioaerosol in the lungs and clearance patterns were recognized based on radioaerosol inhalation lung cine-scintigraphy before and after the administration of salbutamol. In any of the 5 indexes, either, there was no significant statistical difference before and after the administration of salbutamol as shown in Fig. 2 .
DISCUSSION
We have reported previously that the alveolar deposition ratio (ALDR) could be estimated by calculation from a regression equation of ALDR= -48.08+ 0.47 x FEV1.0%+59 x LRR60 . We have made a drug evaluation by using the actually measured ALDR's and the calculated ones from this Fig .1 . Lung retention ratio (LRR), alveolar deposition ratio (LRR at 24 hr), airway deposition ratio, airway retention ratio and airway clearance efficiency in 10 patients in whom oral salbutamol was administered in addition to other medications. The stipled bands are 95°, confidence intervals of normal values of each index (Isawa 1985) . Times indicate times after radioaerosol inhalation. o, before salbutamol ; ., after salbutamol.
regression equation to estimate the other 3 indices before and after the drug administration. The results of a drug evaluation for a mucolytic agent, bromhexine have been the same, whether the actually measured ALDR's or the calculated ones were used to estimate the other indices (Isawa et al. 1986 ). Therefore, the simplified radioaerosol inhalation lung cine-scintigraphy as we have adopted in the present investigation seems justified to be used also for evaluating the effect of oral salbutamol. There are two types of studies to evaluate a drug effect. One is an in vitro study and the other, an in vivo or a clinical study with patients. Ours belongs to the latter type of study and the drug salbutamol was orally administered for a Fig . 2 . Lung retention ratio (LRR), alveolar deposition ratio (LRR at 24 hr), airway deposition ratio, airway retention ratio and airway clearance efficiency in 9 patients in whom oral salbutamol was administered singly without other medications. The stipled bands are 95°/° confidence intervals of normal values of each index (Isawa 1985) . Times indicate times after radioaerosol inhalation. o, before salbutamol ; ., after salbutamol.
week. Salbutamol is a known beta-2 agonist and an effective bronchodilator (Innes and Nickerson 1970) . In case of terbutaline, another beta-2 agonist, which has been most extensively studied, somewhat conflicting results have been reported regarding its effect on clearance of tracheobronchial secretions. Terbutaline inhalation had no effect on the rate of mucociliary clearance (Pavia et al. 1980; Bateman et al. 1983 ), while subcutaneous injection of terbutaline showed an increase (Santa Cruz et al. 1974 ; Camner et al. 1976 ) and a decrease in mucociliary clearance (Santa Cruz et al. 1974 ). Konietzko and others (1975) found that the oral administration of terbutaline to normal subjects produced a significant increase in clearance rate of inhaled technetium-sulfur colloid aerosol, but Sadoul and others (1981) report neither significant effect on mucociliary clearance nor viscoelastic properties of sputum and in vivo transport rate on the frog palate. Weiss and others (1981) described that oral clenbutol, another beta adrenergic agonist, showed a significantly accelerated whole lung clearance.
Van As (1974) demonstrated that ciliary frequency increased when an airway preparation of the rat was exposed to increasing concentrations of salbutamol. An increase in ciliary beat in the isolated preparation of the airways of various animals has been found with isoproterenol (Blair and Woods 1969), NAB365 (Iravani and Melville 1974) , epinephrine, ephedrine and metaproterenol (Melville et al. 1976 ). Isoproterenol and ephedrine are also reported to accelerate mucus clearance within the human tracheobronchial tree (Foster et al. 1976 ). Thus, it appears likely that salbutamol as a beta-2 agonist has a potent cilioexcitatory effect per se (Sackner 1978 ), but the present results using oral salbutamol failed to show any significant effect on mucociliary clearance in man when 4 mg was orally administered 3 times a day for 7 days in combination with other drugs or when it was given singly without being combined with other medications. Lafortuna and Fazio (1984) used salbutamol on 20 patients with bronchitis and 6 healthy subjects and found that both patients and normals treated with inhaled salbutamol showed a significant increase in the rate of clearance when compared with the respective control group receiving placebo. Rossman and others (1980) have also reported, however, no effect of inhaled salbutamol on mucociliary clearance in patients with Kartagener syndrome. As was indicated by lung function data, oral salbutamol in our study tended to elicit some bronchodilation after it was administered singly or in combination with other medications. So it appears likely that oral salbutamol works as a beta-agonist. We could not, however, confirm any significant effect of this drug on mucociliary clearance mechanisms either by the tine-scintigraphic observation or by the quantitative indexes. If salbutamol induces bronchodilation, the fraction of inhaled aerosol depositing more distally on the ciliated airways and the non-ciliated airways and/or the alveolar region might be increased after the administration of the drug ; in other words, inhaled aerosol could penetrate further down the distal airways so that the alveolar deposition ratio might increase. The alveolar deposition ratio is an index of aerosol penetration in the lungs (Isawa et al. 1984a, b) . Actually however, there was little change in the alveolar deposition ratio before and after the administration of oral salbutamol. Therefore, it should be concluded that mucociliary clearance is little effected by the present dose and duration of salbutamol administration.
There is still a possibility that the pharmacological effect of oral salbutamol at our dose level could have been too weak to induce any effect on the mucociliary clearance function. If the dose is increased, however, the patients usually begin to complain of finger tremor and/or palpitation, and we didn't think it wise to increase the dose in this clinical investigation.
Previously we have reported that orally administered bromhexine, a mucolytic agent, definitely improves the airway clearance efficiency by the same methodology (Isawa et al. 1984c ). We expected that salbutamol, which is often used in daily practice, might also improve mucociliary clearance mechanisms both from the clinical impression and the theoretical point of view such as in vitro cilioexcitatory effect (Vas As 1974; Sackner 1978) . The expectation, however, has not been substantiated from the standpoint of mucociliary clearance in the present study. Subjective benefit often experienced by patients with irreversible obstructive airways disease from adding oral salbutamol might be mainly due to bronchodilation itself and probably not due to improvement in mucociliary clearance mechanisms.
